Anthropic’s Dario Amodei ‘not super fussed’ about market turmoil ahead of IPO - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号)。如果该手机号尚未注册,将自动创建 FT中文网账号。短信可能需要几分钟送达,验证码15分钟内有效,请耐心等待:
请您阅读我们的用户注册协议和隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Anthropic’s Dario Amodei ‘not super fussed’ about market turmoil ahead of IPO

AI lab’s chief executive brushes off tech stock turbulence less than a week before its planned $1.5tn IPO
00:00

{"text":[[{"start":10.94,"text":"Anthropic is “not super fussed” about market volatility disrupting the AI lab’s blockbuster initial public offering in less than a week’s time, chief executive Dario Amodei said in an interview with JPMorgan boss Jamie Dimon on Friday."}],[{"start":25.7,"text":"The company is planning to go public on Thursday on the tech-heavy Nasdaq in the teeth of highly volatile trading. US markets have been rocked by anxiety about the sustainability of the AI boom and the sudden resignation of Nvidia boss Jensen Huang."}],[{"start":39.4,"text":"“We’re not super fussed on when exactly, what month or what day, or what market conditions we go public into,” Amodei told bankers and partners at an event with Dimon organised by JPMorgan, ahead of a listing expected to value Anthropic at about $1.5tn."}],[{"start":56.52,"text":"The market ructions led Anthropic investors to trim their valuation outlook from the more than $2tn many expected over the summer. Amodei said his approach to pricing the IPO was “never let your company be worth a single dollar more than it’s really worth”."}],[{"start":70.9,"text":"The Anthropic co-founder added that the listing was a way for the company to maximise its cash on hand and ensure it could meet huge spending plans for new computing power and infrastructure."}],[{"start":80.12,"text":"“Compute is the deepest business dilemma that the company faces,” said Amodei. Anthropic could raise a record-breaking $100bn or more in the IPO and a simultaneous private placement deal."}],[{"start":91.84,"text":"“This field is growing so fast from a technological perspective and we don’t know how that is going to transfer to the creation of economic value on the business side . . . We don’t know what’s going to happen next year,” he added."}],[{"start":null,"text":"

Dario Amodei gestures with one hand while speaking during an interview, seated indoors.
"}],[{"start":103.94,"text":"The five-year-old company had more than $130bn in cash on hand at the end of September. The IPO, which is oversubscribed, could almost double that and give Anthropic a “buffer” to meet its planned $900bn in infrastructure spending over the coming years, and to deal with any shocks."}],[{"start":119.24,"text":"Amodei acknowledged that the “commitments are very large”. But he said the spending may be too conservative compared with the company’s growth prospects, in which case Anthropic would buy additional compute in the short-term “spot market”."}],[{"start":133.36,"text":"Anthropic has struck deals with Elon Musk’s SpaceX worth as much as $3.1bn per month to use the rocket maker’s data centre capacity. Short-term deals such as the arrangement with Musk “cost more but we’re buying it in a world where we’re doing particularly well”, said Amodei."}],[{"start":151.08,"text":"The Anthropic boss also said he was not concerned about advanced AI becoming a commodity, which would erode the lab’s lead over rivals. While the market for certain applications, such as chatbots or coding tools, might become saturated, Amodei told Dimon he was confident that exponential growth in cognitive power or AI would open new markets."}],[{"start":173.04,"text":"JPMorgan is an underwriter on Anthropic’s listing, managing sales to retail investors in the US. Amodei told the assembled bankers at the group’s New York offices that his biggest preoccupation was cultivating Anthropic’s culture."}],[{"start":185.28,"text":"“We don’t want people who are jerks. We don’t want people who try to steal the show and don’t work well with others. We don’t want people who aren’t oriented towards the public benefit.”"}],[{"start":199.98,"text":""}]],"url":"https://audio.ftcn.net.cn/album/a_1794620930_9824.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

英伟达董事会的虚假独立性

治理话题令人犯困。

中国科技股大幅回落,投资AI或许少些波折

中国的机遇同样蕴藏在AI供应链的“卖铲人”环节。

英伟达的个人崇拜注定不会善终

值得留意企业傲慢自大的警讯——这往往意味着坏事即将发生。

无根之人最终赢了

人们或许不会投票支持自由个人主义,但他们践行着它。

耗资5亿美元的罗摩衍那押注全球成功

宝莱坞史上成本最高的电影更看重CGI视觉奇观,而非精神震撼——但要收回成本,或许还得靠奇迹。

我们很快就能治愈癌症吗?

近期,药物预防和治疗领域的革命性进展让科学家距离战胜这些最令人恐惧的疾病仅一步之遥,但棘手的挑战依然存在。
设置字号×
最小
较小
默认
较大
最大
分享×